• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

BOLD ALLERGAN why ichan sold his shares


<



First Shoe has dropped:
• The FTC has sued Allergan (AGN +0.7%) and Endo International (ENDP -5.3%) in federal court alleging an agreement between the two obstructed generic drug competition.
• TEVA -3%
ichan is a "Special Adviser" to Trump and he offloaded all his AGN shares due to Non-GAAP accounting practices.
Second BOOT is coming.
 








Similar threads

Replies
2
Views
2K
Replies
9
Views
3K
Replies
5
Views
2K
Replies
6
Views
3K
Allergan
anonymous